Brainsway Ltd.
Develops noninvasive neurostimulation treatments for mental health and addiction.
BWAY | TA
Overview
Corporate Details
- ISIN(s):
- IL0011007189
- LEI:
- Country:
- Israel
- Address:
- 16 Hartum St, 9777516 Har Hotzvim, Jerusalem
- Website:
- https://www.brainsway.com/
- Sector:
- Manufacturing
Description
Brainsway Ltd. is a medical technology company focused on developing and marketing advanced noninvasive neurostimulation treatments for mental health and addictive disorders. The company's core product is its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) system, which uses a patented H-coil to stimulate deeper and broader regions of the brain. The technology is designed as a safe and effective non-drug treatment option. The Deep TMS system has received multiple FDA clearances for conditions including Major Depressive Disorder (MDD), anxious depression, and Obsessive-Compulsive Disorder (OCD), for which it was the first noninvasive medical device to receive such clearance. It is also FDA-cleared as an aid for short-term smoking cessation, the first TMS device to be cleared for an addiction indication.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-06-01 16:59 |
Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administ…
|
English | 36.2 KB | ||
| 2021-05-24 16:59 |
Announces First of its Kind Coverage Policy by Centene for the Treatment of OCD…
|
English | 151.8 KB | ||
| 2021-05-24 16:59 |
Announces First of its Kind Coverage Policy by Centene for the Treatment of OCD…
|
English | 36.2 KB | ||
| 2021-05-24 16:29 |
BrainsWay Updates Line Item in 2021 First Quarter Financial Results
|
English | 96.7 KB | ||
| 2021-05-24 16:29 |
BrainsWay Updates Line Item in 2021 First Quarter Financial Results
|
English | 36.1 KB | ||
| 2021-05-20 16:59 |
Reports First Quarter 2021 Financial Results and Operational Highlights
|
English | 142.3 KB | ||
| 2021-05-20 16:59 |
Reports First Quarter 2021 Financial Results and Operational Highlights
|
English | 36.1 KB | ||
| 2021-05-05 16:59 |
Appointment of R. Scott Areglado as Senior Vice President and Chief
Financial …
|
English | 119.4 KB | ||
| 2021-05-05 16:59 |
Appointment of R. Scott Areglado as Senior Vice President and Chief
Financial …
|
English | 36.1 KB | ||
| 2021-05-04 18:49 |
Offer to Exchange Eligible Options for New Options
|
English | 484.9 KB | ||
| 2021-05-04 18:49 |
Offer to Exchange Eligible Options for New Options
|
English | 36.0 KB | ||
| 2021-04-26 16:29 |
Receives FDA Clearance for Three Minute Theta Burst Depression Treatment Protoc…
|
English | 253.3 KB | ||
| 2021-04-26 16:29 |
Receives FDA Clearance for Three Minute Theta Burst Depression Treatment Protoc…
|
English | 36.2 KB | ||
| 2021-04-20 01:38 |
BrainsWay 2020 Form 20-F
|
English | 1.7 MB | ||
| 2021-04-20 01:38 |
BrainsWay 2020 Form 20-F
|
English | 35.9 KB |
Automate Your Workflow. Get a real-time feed of all Brainsway Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Brainsway Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Brainsway Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
